COMPARATIVE STUDY OF LABETALOL AND NIFEDIPINE IN MANAGEMENT OF HYPERTENSIVE DISORDERS OF PREGNANCY

HARSHITHA K.; KOLAN PALLAVI

doi:10.22159/ijcpr.2024v16i5.5020

Authors

HARSHITHA K. ESIC Hospital, Sanath Nagar, Hyderabad, India
KOLAN PALLAVI Department of Obstetrics, Dr. Patnam Mahender Reddy Institute of Medical Sciences, Chevella, Ranga Reddy District, Telangana, India

DOI:

https://doi.org/10.22159/ijcpr.2024v16i5.5020

Keywords:

Nifedipine, Labetalol, Hypertension, Fetal outcome, Pregnancy

Abstract

Objective: The purpose of the study was to evaluate and compare effectiveness and safety of nifedipine and labetalol monotherapy in patients with hypertensive disorders of pregnancy.

Methods: 100 antenatal patients were selected. Detailed obstetric history was taken and, clinical examination done and the blood pressure was checked and means arterial pressure was calculated as follows (SBP+2DBP)/3. Brachial artery blood pressure was checked with the patient in lateral recumbent position using calibrated mercury sphygmomanometer and appropriate cuff size. Korotkoff V was used to determine diastolic blood pressure. The blood pressure was monitored at 0, 6, 12, 24, 48, 72 h. The initial dosage of an antihypertensive drug and maximum dosage of the antihypertensive drug was observed.

Results: In the present study, it was noted that the change in mean arterial pressure from the time of admission to 72 h were noted in the two groups which received nifedipine (132.34 vs 96.74) and labetalol (132.07 vs 93.51). There was a significant fall in the mean arterial pressure at 6 h in nifedipine group which showed statistical difference. At 48 h and 72 h fall in MAP was noted in labetalol group, which is statistically significant. The study showed that there was a sudden fall in the mean arterial pressure in nifedipine group, but labetalol had smooth and persistent fall in mean arterial pressure. It was observed in the study that fetal outcome in terms of live births (96% vs 84%) was higher in labetalol group and need for NICU admission and preterm births (18% vs 10%) was more in nifedipine group.

Conclusion: The present study has shown that labetalol has got better and sustained control of hypertension in pregnancy.

Downloads

Download data is not yet available.

References

Lee K, Brayboy L, Tripathi A. Pre-eclampsia: a scoping review of risk factors and suggestions for future research direction. Regen Eng Transl Med. 2022;8(3):394-406. doi: 10.1007/s40883-021-00243-w, PMID 35571151, PMCID PMC9090120.

Aparna J. A randomized double-blind comparative trial of nifedipine and methyldopa in moderate pregnancy-induced hypertension. Pharm Lett. 2013;5(4):274-7.

Roberts JM, Pearson G, Cutler J, Lindheimer M, NHLBI working group on research on hypertension during pregnancy. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension. 2003;41(3):437-45. doi: 10.1161/01.HYP.0000054981.03589.E9, PMID 12623940.

Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77(2):154-8. doi: 10.1136/hrt.77.2.154, PMID 9068399.

Zulfeen M, Tatapudi R, Sowjanya R. Erratum to IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2020;247:46-52. doi: 10.1016/j.ejogrb.2020.01.020, PMID 31980290.

Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol. 1987;70:328-33, PMID 3306494.

Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol. 1991;77(3):331-7. PMID 1992393.

Hangarga US, Rita D, Harshitha K. Comparative study of labetalol and nifedipine in management of hypertensive disorders in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;6(1):194-7. doi: 10.18203/2320-1770.ijrcog20164656.

Deshmukh UB, A S, Tengli S. Comparative study of labetalol and nifedipine in management of hypertensive disorders of pregnancy in BRIMS tertiary care center. New Indian J Obgyn. 2021;8(1):117-20. doi: 10.21276/obgyn.2021.8.1.22.

Patel NK, Gadhavi M, Gorasia D, Pandya MR. Comparative evaluation of antihypertensive drugs in the management of pregnancy-induced hypertension. Int J Basic Clin Pharmacol. 2012;1(3):174-7. doi: 10.5455/2319-2003.ijbcp003412.

McDonald AJ, Yealy DM, Jacobson S. Oral labetalol versus oral nifedipine in hypertensive urgencies in the ED. Am J Emerg Med. 1993;11(5):460-3. doi: 10.1016/0735-6757(93)90083-n, PMID 8363681.

SD, Novri DA, Hamidy Y, Savira M. Effectiveness of nifedipine labetalol and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial. F1000Res. 2022;11:1287. doi: 10.12688/f1000research.125944.2, PMID 37273965, PMCID PMC10238817.